Institutional investors purchased a net $800.0 thousand shares of CBLI during the quarter ended December 2012, and now own 12.61% of the total float, a percentage that is typical for companies in the Biotechnology industry.
| Mutual fund holders | 2.33% |
| Individual stakeholders | 14.05% |
| Other institutional | 10.28% |